SCHEMBL7662956

SCHEMBL7662956

CCCCC[C@@H](C=C[C@@H]1[C@@H](CC=CCCC(=O)O)[C@@H](O)C[C@H]1OC1CCCCO1)OC1CCCCO1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGFR P43088 6/20 0.51
▸ TBXA2R P21731 5/20 0.51
▸ LMNA P02545 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ PTGER1 P34995 2/20 0.51
▸ PTGER3 P43115 2/20 0.51
▸ PTGER4 P35408 1/20 0.51
▸ PTGDR Q13258 1/20 0.51
▸ SLCO2A1 Q92959 1/20 0.51
▸ PDE4D Q08499 4/20 0.49
▸ HPGD P15428 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ ABCC4 O15439 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ HKDC1 Q2TB90 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ SAE1 Q9UBE0 1/20 0.45
▸ UBA2 Q9UBT2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868801 1.00 PTGFR (0.51) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL7662953 1.00 PTGFR (0.51) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL24727258 0.96 TBXA2R (0.56) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL11177889 0.96 TBXA2R (0.56) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL7672711 0.92 PDE4D (0.57) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL7672718 0.92 PDE4D (0.57) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL7672708 0.92 PDE4D (0.57) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL10866409 0.92 TBXA2R (0.59) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL11177219 0.90 PDE4D (0.62) PTGFRTBXA2RLMNAALDH1A1PTGER1
SCHEMBL7669266 0.89 PDE4D (0.47) PTGFRTBXA2RLMNAALDH1A1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6359181-B1 THERAPY FOR VISION DEFECTS ALLERGAN SALES, INC. 2002-03-19 — — US disclosed
US-6307092-B1 POTENT OCULAR HYPOTENSIVES AND ARE PARTICULARLY SUITED FOR THE MANAGEMENT OF GLAUCOMA. ALLERGAN SALES, INC. 2001-10-23 — — US disclosed
US-6248783-B1 GLAUCOMA THERAPY ALLERGAN SALES, INC. 2001-06-19 — — US disclosed
Send feedback